Feng Li
Chief Executive Officer at Beijing Mabworks Biotech Co., Ltd.
Profile
Feng Li is currently the Chairman, President & General Manager at Beijing Mabworks Biotech Co., Ltd., a Non-Executive Director at Shanghai Duoning Biotechnology Co., Ltd., and the General Partner at Tibet Huatai Tianshi Enterprise Management Partnership LP.
Dr. Li holds a doctorate degree from Rice University, a graduate degree from Lehigh University, a graduate degree from Tsinghua University, and an undergraduate degree from Shanghai Jiao Tong University.
Feng Li active positions
Companies | Position | Start |
---|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Chief Executive Officer | 2012-01-31 |
Shanghai Duoning Biotechnology Co., Ltd.
Shanghai Duoning Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Duoning Biotechnology Co., Ltd. develops, manufactures, and supplies serum-free culture medium, disposable bioreactors, and laboratory products. The company is based in Shanghai, China. The Chinese company was founded in 2005 by Meng Wang, who has been the CEO since 2005. | Director/Board Member | 2018-08-26 |
Tibet Huatai Tianshi Enterprise Management Partnership LP | Corporate Officer/Principal | - |
Training of Feng Li
Rice University | Doctorate Degree |
Lehigh University | Graduate Degree |
Tsinghua University | Graduate Degree |
Shanghai Jiao Tong University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
Shanghai Duoning Biotechnology Co., Ltd.
Shanghai Duoning Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Duoning Biotechnology Co., Ltd. develops, manufactures, and supplies serum-free culture medium, disposable bioreactors, and laboratory products. The company is based in Shanghai, China. The Chinese company was founded in 2005 by Meng Wang, who has been the CEO since 2005. | Health Technology |
Tibet Huatai Tianshi Enterprise Management Partnership LP |
- Stock Market
- Insiders
- Feng Li